Bone and cancer: the osteoncology

Area of Science:

• Oncology
• Orthopedics
• Pharmacology

Background:

• Improved patient survival has increased bone metastases incidence.
• Bone metastases significantly impact cancer patient morbidity.
• Osteoncology is a new branch managing bone cancer and metastases.

Purpose of the Study:

• To introduce osteoncology as a field.
• To discuss Cancer Treatment Induced Bone Loss (CTIBL).
• To highlight the importance of a multidisciplinary approach.

Main Methods:

• Review of clinical observations.
• Brief description of diagnostic options.
• Brief description of therapeutic options.

Main Results:

• Osteoncology is a growing field.
• Cancer Treatment Induced Bone Loss (CTIBL) is a key topic.
• Multidisciplinary care is crucial.

Conclusions:

• Osteoncology addresses the evolving relationship between bone and cancer.
• Effective management requires a collaborative, multidisciplinary approach.
• Further research and clinical focus on osteoncology are warranted.